ArticleACS applied bio materials2025
Bovine Serum Albumin-Trypsin Sponges for Enhanced Enzymatic Stability and Protein Digestion Efficiency.
Article in ACS applied bio materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Corundum Particles as Trypsin Carrier for Efficient Protein Digestion.Biotech (Basel (Switzerland)) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein-based materials are emerging as versatile platforms for biocatalysis and biomedical applications due to their structural tunability and intrinsic catalytic capabilities. Here, we present a light-activated strategy for the scalable fabrication of enzymatically active sponges via covalent cross-linking of trypsin within a bovine serum albumin (BSA) matrix. This method leverages photoinitiated Tyr-Tyr coupling, creating a nanoscale enzyme distribution that addresses critical limitations observed in conventional enzyme immobilization methods─namely, instability, autolysis, and restricted reusability. By modulating trypsin concentration and acetic acid (AA) during synthesis, we achieve precise control over cross-link density, enhancing both mechanical flexibility and catalytic accessibility. The sponges retain over 50% of their enzymatic activity after 30 days of storage and maintain ∼60% functionality across ten reuse cycles. Structural integrity and enzyme distribution were validated by attenuated total reflection-Fourier transform infrared (ATR-FTIR) and fluorescence resonance energy transfer (FRET) microscopy, revealing preserved secondary structure and uniform spatial embedding. Proteolytic performance was benchmarked against Cytochrome c, Concanavalin A, and Fetal Bovine Serum, demonstrating enhanced cleavage efficiency and substrate accessibility. This light-activated, reusable platform introduces a scalable approach for stable enzyme immobilization with broad implications for proteomics, biocatalysis, therapeutic devices, and advanced biomedical diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.